Citation Impact
Citing Papers
In Vitro Susceptibilities of Candida spp. to Caspofungin: Four Years of Global Surveillance
2006
Clinical Practice Guidelines for the Management Candidiasis: 2009 Update by the Infectious Diseases Society of America
2009 Standout
Clinical Practice Guidelines for the Management of Cryptococcal Disease: 2010 Update by the Infectious Diseases Society of America
2010 Standout
Epidemiology of Invasive Candidiasis: a Persistent Public Health Problem
2007 Standout
Diagnosis and Management of Complicated Intra-abdominal Infection in Adults and Children: Guidelines by the Surgical Infection Society and the Infectious Diseases Society of America
2009 Standout
Epidemiology of and Diagnostic Strategies for Toxoplasmosis
2012 Standout
Early Versus Delayed Antiretroviral Therapy and Cerebrospinal Fluid Fungal Clearance in Adults With HIV and Cryptococcal Meningitis
2013 StandoutNobel
Mucormycosis (Zygomycosis) in a Heart-Kidney Transplant Recipient: Recovery after Posaconazole Therapy
2003
Aspergillosis: Spectrum of Disease, Diagnosis, and Treatment
2006
The re-emergence of natural products for drug discovery in the genomics era
2015 Standout
Early versus Delayed Initiation of Antiretroviral Therapy for Concurrent HIV Infection and Cryptococcal Meningitis in Sub‐Saharan Africa
2010
Pharmacologically prospective antibiotic agents and their sources: A marine microbial perspective
2012
Impact of Treatment Strategy on Outcomes in Patients with Candidemia and Other Forms of Invasive Candidiasis: A Patient-Level Quantitative Review of Randomized Trials
2012 Standout
Recommendations for managing Aspergillus osteomyelitis and joint infections based on a review of the literature
2005
Mangromicins A and B: structure and antitrypanosomal activity of two new cyclopentadecane compounds from Lechevalieria aerocolonigenes K10-0216
2013 StandoutNobel
Guidelines for Preventing Infectious Complications among Hematopoietic Cell Transplantation Recipients: A Global Perspective
2009 Standout
Successful Treatment of Rhinocerebral Mucormycosis with Liposomal Amphotericin B and Surgery in Two Diabetic Patients with Renal Dysfunction
2003
Posaconazole or Fluconazole for Prophylaxis in Severe Graft-versus-Host Disease
2007 Standout
Toll-like Receptor 1 Polymorphisms Increase Susceptibility to Candidemia
2012
Marine natural products
1990 Standout
Triazole‐Polyene Antagonism in Experimental Invasive Pulmonary Aspergillosis: In Vitro and In Vivo Correlation
2006
Drug discovery from natural sources
2006
Aspergillus Bronchitis in Cystic Fibrosis
2006
Aspergillus fumigatus Stimulates the NLRP3 Inflammasome through a Pathway Requiring ROS Production and the Syk Tyrosine Kinase
2010
Safety of aerosolized liposomal versus deoxycholate amphotericin B formulations for prevention of invasive fungal infections following lung transplantation: a retrospective study
2007
Anidulafungin: a new echinocandin for candidal infections
2007
Voriconazole Therapeutic Drug Monitoring in Patients with Invasive Mycoses Improves Efficacy and Safety Outcomes
2007 Standout
Safety of Long-Term Oral Posaconazole Use in the Treatment of Refractory Invasive Fungal Infections
2006
Amphotericin B lipid complex: treatment of invasive fungal infections in patients refractory to or intolerant of amphotericin B deoxycholate
2008
Epidemiology and Outcome of Zygomycosis: A Review of 929 Reported Cases
2005 Standout
A Single Center's Experience withCandida parapsilosisRelated Long-Term Central Venous Access Device Infections: The Port Removal Decision and Its Outcomes
2014
Voriconazole Treatment for Less‐Common, Emerging, or Refractory Fungal Infections
2003
Bad Bugs Need Drugs: An Update on the Development Pipeline from the Antimicrobial Availability Task Force of the Infectious Diseases Society of America
2006 Standout
Natural products to drugs: natural product-derived compounds in clinical trials
2008 Standout
Bench-to-bedside review: Candida infections in the intensive care unit
2008
Newer Systemic Antifungal Agents
2004
Transglutaminases: crosslinking enzymes with pleiotropic functions
2003 Standout
Advances and Challenges of Liposome Assisted Drug Delivery
2015 Standout
Infections due to emerging and uncommon medically important fungal pathogens
2004
Posaconazole: a broad-spectrum triazole antifungal
2005
Invasive pulmonary aspergillosis in patients with chronic obstructive pulmonary disease
2007
Liposomal amphotericin B in combination with caspofungin for invasive aspergillosis in patients with hematologic malignancies
2007
Mechanisms of drug combinations: interaction and network perspectives
2009 Standout
Efficacy and Safety of Amphotericin B Lipid Complex in 548 Children and Adolescents With Invasive Fungal Infections
2005
Renal impairment and Amphotericin B formulations in patients with invasive fungal infections
2008
Combined Antifungal Treatment of Visceral Mucormycosis with Caspofungin and Liposomal Amphotericin B
2002
Neo‐ligands for innate immune receptors and the etiology of sterile inflammatory disease
2007 StandoutNobel
Mucormycosis and entomophthoramycosis: a review of the clinical manifestations, diagnosis and treatment
2004
Zygomycosis (mucormycosis): emerging clinical importance and new treatments
2004
Simultaneous Emergence of Multidrug-Resistant Candida auris on 3 Continents Confirmed by Whole-Genome Sequencing and Epidemiological Analyses
2016 Standout
T2 Magnetic Resonance Assay for the Rapid Diagnosis of Candidemia in Whole Blood: A Clinical Trial
2015
Antifungal agents – clinical pharmacokinetics and drug interactions
2008
Mycoses in Pediatric Patients
2006
The effect of aminocandin (HMR 3270) on the in-vitro adherence of Candida albicans to polystyrene surfaces coated with extracellular matrix proteins or fibronectin
2006
Antifungal Agents in Children
2005
Essential Role of theCandida albicansTransglutaminase Substrate, Hyphal Wall Protein 1, in Lethal Oroesophageal Candidiasis in Immunodeficient Mice
2002
Caspofungin: the first in a new class of antifungal agents
2003
Natural products to drugs: natural product derived compounds in clinical trials
2005
Advances and challenges in management of invasive mycoses
2005
Enhancement of metabolites productivity of Penicillium pinophilum FKI-5653, by co-culture with Trichoderma harzianum FKI-5655
2011 StandoutNobel
Immunity to fungal infections
2011 Standout
Candidaemia associated with decreased in vitro fluconazole susceptibility: is Candida speciation predictive of the susceptibility pattern?
2010
Discovery and resupply of pharmacologically active plant-derived natural products: A review
2015 Standout
Natural products in drug discovery
2008 Standout
Epidemiology and Microbiologic Characterization of Nosocomial Candidemia from a Brazilian National Surveillance Program
2016
Galactomannan and Computed Tomography-Based Preemptive Antifungal Therapy in Neutropenic Patients at High Risk for Invasive Fungal Infection: A Prospective Feasibility Study
2005
Antifungal agents: mechanisms of action
2003 Standout
The invasive and saprophytic syndromes due toAspergillusspp.
2005
Posaconazole vs. Fluconazole or Itraconazole Prophylaxis in Patients with Neutropenia
2007 Standout
Fusobacterium nucleatum — symbiont, opportunist and oncobacterium
2018 Standout
High level of soluble HLA-G in amniotic fluid is correlated with congenital transmission of Toxoplasma gondii
2010
An Official American Thoracic Society Statement: Treatment of Fungal Infections in Adult Pulmonary and Critical Care Patients
2010
Specific Substitutions in the Echinocandin Target Fks1p Account for Reduced Susceptibility of Rare Laboratory and Clinical Candida sp. Isolates
2005
Practice Guidelines for the Diagnosis and Management of Skin and Soft Tissue Infections: 2014 Update by the Infectious Diseases Society of America
2014 Standout
Combination Treatment of Invasive Fungal Infections
2005
Fluorine in Pharmaceutical Industry: Fluorine-Containing Drugs Introduced to the Market in the Last Decade (2001–2011)
2013 Standout
Pulmonary rehabilitation for chronic obstructive pulmonary disease
2015 Standout
Guidelines for the Prevention and Treatment of Opportunistic Infections among HIV-exposed and HIV-infected children: recommendations from CDC, the National Institutes of Health, the HIV Medicine Association of the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the American Academy of Pediatrics.
2009
Diagnosis, evaluation, and management of acute kidney injury: a KDIGO summary (Part 1)
2013 Standout
Evolution of Invasion in a Diverse Set of Fusobacterium Species
2014
2016 Infectious Diseases Society of America (IDSA) Clinical Practice Guideline for the Treatment of Coccidioidomycosis
2016 Standout
Molecular mechanisms and functions of pyroptosis, inflammatory caspases and inflammasomes in infectious diseases
2017 Standout
Cutaneous Fungal Infections in the Oncology Patient
2006
The Hidden World within Plants: Ecological and Evolutionary Considerations for Defining Functioning of Microbial Endophytes
2015 Standout
Clinical Practice Guideline for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer: 2010 Update by the Infectious Diseases Society of America
2011 Standout
Invasive Candidiasis
2015 Standout
Further Standardization of Broth Microdilution Methodology for In Vitro Susceptibility Testing of Caspofungin against Candida Species by Use of an International Collection of More than 3,000 Clinical Isolates
2004
Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America
2016 Standout
Pharmacology of Systemic Antifungal Agents
2006
Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America
2015 Standout
Munumbicins, wide-spectrum antibiotics produced by Streptomyces NRRL 30562, endophytic on Kennedia nigriscans a aThe GenBank accession number for the sequence determined in this work is AY127079.
2002
Use of Plant Growth-Promoting Bacteria for Biocontrol of Plant Diseases: Principles, Mechanisms of Action, and Future Prospects
2005 Standout
Rare and Emerging Opportunistic Fungal Pathogens: Concern for Resistance beyondCandida albicansandAspergillus fumigatus
2004
Treatment of Aspergillosis: Clinical Practice Guidelines of the Infectious Diseases Society of America
2008 Standout
Pharmacokinetics, Safety, and Efficacy of Posaconazole in Patients with Persistent Febrile Neutropenia or Refractory Invasive Fungal Infection
2006
2013 IDSA Clinical Practice Guideline for Vaccination of the Immunocompromised Host
2013 Standout
The Traditional Medicine and Modern Medicine from Natural Products
2016 Standout
Echinocandins: role in antifungal therapy, 2005
2005
Secretion of Proinflammatory Cytokines and Chemokines during Amphotericin B Exposure Is Mediated by Coactivation of Toll-Like Receptors 1 and 2
2005
Hidden Killers: Human Fungal Infections
2012 Standout
Bioprospecting for Microbial Endophytes and Their Natural Products
2003 Standout
Clinical Practice Guidelines for the Management of Patients with Histoplasmosis: 2007 Update by the Infectious Diseases Society of America
2007 Standout
Works of V. Letscher‐Bru being referenced
Management of systemic fungal infections: alternatives to itraconazole
2005
Efficacy of Amphotericin B Lipid Complex in the Treatment of Invasive Fungal Infections in Immunosuppressed Paediatric Patients
2001
Invasive aspergillosis in the hematologic and immunologic patient: new findings and key questions in leukemia
2005
Combination of caspofungin and an azole or an amphotericin B formulation in invasive fungal infections
2005
Treatment of 21 Cases of Invasive Mucormycosis with Amphotericin B Colloidal Dispersion
2001
Fungal Infections in Patients With Neutropenia
2000
Chronic DisseminatedTrichosporon asahiiInfection in a Leukemic Child
2002
Cellular and molecular physiopathology of congenital toxoplasmosis: The dual role of IFN-γ
2007
Isolated Renal Aspergillus Abscess in an AIDS Patient with a Normal CD4+ Cell Count on Highly Active Antiretroviral Therapy
1999
Acremonium strictum Pulmonary Infection in a Leukemic Patient Successfully Treated with Posaconazole After Failure of Amphotericin B
2002
Caspofungin: the first representative of a new antifungal class
2003
Amphotericin B and its new formulations: pharmacologic characteristics, clinical efficacy, and tolerability
1999
Results from the ARTEMIS DISK Global Antifungal Surveillance Study, 1997 to 2007: 10.5-Year Analysis of Susceptibilities of Noncandidal Yeast Species to Fluconazole and Voriconazole Determined by CLSI Standardized Disk Diffusion Testing
2008